Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates For The Next Quarter

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter. Abaxis

is estimated to post earnings of $0.24 per share in the June quarter. Abaxis' trailing-twelve-month revenue is $178.79 million. Meridian Bioscience

is expected to earn $0.22 per share in the June quarter. Meridian Bioscience's trailing-twelve-month operating margin is 29.72%. SurModics

is likely to earn $0.22 per share in the June quarter. SurModics had $30.96 million in total cash for the latest quarter. Trinity Biotech plc

may earn $0.20 per share in the March quarter. Trinity Biotech's PEG ratio is 1.88.